Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Core EBITDA Growth

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023
   Core EBITDA Growth(%) 347.3496.47-

What is the latest Core EBITDA Growth ratio of GENPHARMASEC ?

The latest Core EBITDA Growth ratio of GENPHARMASEC is 347.34 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025347.34
Mar202496.47
Mar2023-

How is Core EBITDA Growth of GENPHARMASEC Trending?

Years Core EBITDA Growth % Change
Mar2025 347.34
260.05
Mar2024 96.47
0
Mar2023 0 -

Other Financial Ratios of GENPHARMASEC


Compare Core EBITDA Growth ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹75.9 Cr -0.7% -8.1% -64.6% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,881.9 Cr 0.7% -2.7% -10% Stock Analytics
KIRI INDUSTRIES ₹3,333.4 Cr -9% 6.3% -7.3% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,690.6 Cr 1.2% -0.4% -37.6% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,205.4 Cr -6.1% -7.2% 11% Stock Analytics
BODAL CHEMICALS ₹655.3 Cr 0% -11.2% -32.6% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-0.7%

-8.1%

-64.6%

SENSEX

-0.5%

1.1%

3.8%


You may also like the below Video Courses